mortality/aging
|
• viable embryos were not observed after E6.5
|
Analysis Tools|
Allele Symbol Allele Name Allele ID |
Mettm2Gvw targeted mutation 2, George Vande Woude MGI:3521827 |
| Summary |
2 genotypes |
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• viable embryos were not observed after E6.5
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• shorter lifespan (15.9 months) compared to controls (20.5 months)
|
|
• 89.5% tumor incidence compared to 44.4% in controls, with some developing multiple cancers
|
|
• 32% developed lymphomas, mainly histiocytic sarcomas
|
|
• 63% developed sarcomas, mainly hemangiosarcomas
|
|
• trisomy and tetrasomy of chromosome 6 and duplication of the mutant Met allele were observed in tumors
|
|
• infrequent to moderate incidence of glomerulonephritis
|
|
• infrequent to moderate incidence of glomerulonephritis
|
|
• infrequent to moderate incidence of hydronephrosis
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 09/30/2025 MGI 6.24 |
|
|
|
||


